ReviewJournal for immunotherapy of cancer2023

Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.

Vladimir Laletin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.